Clinical trial
GER-009-06-AVX Early Therapy in Multiple Sclerosis
NCT00492570 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00492570 |
|---|---|
| Title | GER-009-06-AVX Early Therapy in Multiple Sclerosis |
| Official title | GER-009-06-AVX Early Therapy in Multiple Sclerosis |
| Acronym | FIT |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Relapsing-Remitting Multiple Sclerosis |
| Enrollment | 230 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Jun 16, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: